Literature DB >> 22288682

Interleukin-2, Interleukin-7, T cell-mediated autoimmunity, and N-glycosylation.

Ani Grigorian1, Haik Mkhikian, Michael Demetriou.   

Abstract

T cell activation and self-tolerance are tightly regulated to provide effective host defense against foreign pathogens while deflecting inappropriate autoimmune responses. Golgi Asn (N)-linked protein glycosylation coregulates homeostatic set points for T cell growth, differentiation, and self-tolerance to influence risk of autoimmune disorders such as multiple sclerosis (MS). Human autoimmunity is a complex trait that develops from intricate and poorly understood interactions between an individual's genetics and their environmental exposures. Recent evidence from our group suggests that in MS, additive and/or epistatic interactions between multiple genetic and environmental risk factors combine to dysregulate a common biochemical pathway, namely Golgi N-glycosylation. Here, we review the multiple regulatory mechanisms controlling N-glycan branching in T cells and autoimmunity, focusing on recent data implicating a critical role for interleukin-2 (IL-2) and IL-7 signaling.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22288682      PMCID: PMC4520414          DOI: 10.1111/j.1749-6632.2011.06391.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  69 in total

Review 1.  Immunology: improving on nature in the twenty-first century.

Authors:  A K Abbas; C A Janeway
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions.

Authors:  C Fred Brewer; M Carrie Miceli; Linda G Baum
Journal:  Curr Opin Struct Biol       Date:  2002-10       Impact factor: 6.809

3.  IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion.

Authors:  Warren N D'Souza; Leo Lefrançois
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

4.  Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1.

Authors:  K E Pace; C Lee; P L Stewart; L G Baum
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

5.  N-acetylglucosamine inhibits T-helper 1 (Th1)/T-helper 17 (Th17) cell responses and treats experimental autoimmune encephalomyelitis.

Authors:  Ani Grigorian; Lindsey Araujo; Nandita N Naidu; Dylan J Place; Biswa Choudhury; Michael Demetriou
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

6.  A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease.

Authors:  S Salvatore; R Heuschkel; S Tomlin; S E Davies; S Edwards; J A Walker-Smith; I French; S H Murch
Journal:  Aliment Pharmacol Ther       Date:  2000-12       Impact factor: 8.171

7.  Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis.

Authors:  Emily A Partridge; Christine Le Roy; Gianni M Di Guglielmo; Judy Pawling; Pam Cheung; Maria Granovsky; Ivan R Nabi; Jeffrey L Wrana; James W Dennis
Journal:  Science       Date:  2004-10-01       Impact factor: 47.728

8.  T cell receptor signaling co-regulates multiple Golgi genes to enhance N-glycan branching.

Authors:  Hung-Lin Chen; Carey Fei Li; Ani Grigorian; Wenqiang Tian; Michael Demetriou
Journal:  J Biol Chem       Date:  2009-08-25       Impact factor: 5.157

9.  Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4.

Authors:  B Sadlack; R Kühn; H Schorle; K Rajewsky; W Müller; I Horak
Journal:  Eur J Immunol       Date:  1994-01       Impact factor: 5.532

10.  Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis.

Authors:  Haik Mkhikian; Ani Grigorian; Carey F Li; Hung-Lin Chen; Barbara Newton; Raymond W Zhou; Christine Beeton; Sevan Torossian; Gevork Grikor Tatarian; Sung-Uk Lee; Ken Lau; Erin Walker; Katherine A Siminovitch; K George Chandy; Zhaoxia Yu; James W Dennis; Michael Demetriou
Journal:  Nat Commun       Date:  2011       Impact factor: 14.919

View more
  17 in total

Review 1.  Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.

Authors:  Stefan Bittner; Heinz Wiendl
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

2.  Peripherally Induced Tolerance Depends on Peripheral Regulatory T Cells That Require Hopx To Inhibit Intrinsic IL-2 Expression.

Authors:  Andrew Jones; Adeleye Opejin; Jacob G Henderson; Cindy Gross; Rajan Jain; Jonathan A Epstein; Richard A Flavell; Daniel Hawiger
Journal:  J Immunol       Date:  2015-07-13       Impact factor: 5.422

3.  N-glycosylation bidirectionally extends the boundaries of thymocyte positive selection by decoupling Lck from Ca²⁺ signaling.

Authors:  Raymond W Zhou; Haik Mkhikian; Ani Grigorian; Amanda Hong; David Chen; Araz Arakelyan; Michael Demetriou
Journal:  Nat Immunol       Date:  2014-09-28       Impact factor: 25.606

Review 4.  Pathogenesis of multiple sclerosis via environmental and genetic dysregulation of N-glycosylation.

Authors:  Ani Grigorian; Haik Mkhikian; Carey F Li; Barbara L Newton; Raymond W Zhou; Michael Demetriou
Journal:  Semin Immunopathol       Date:  2012-04-11       Impact factor: 9.623

Review 5.  Emerging role of protein modification in inflammatory bowel disease.

Authors:  Gaoying Wang; Jintao Yuan; Ji Luo; Dickson Kofi Wiredu Ocansey; Xu Zhang; Hui Qian; Wenrong Xu; Fei Mao
Journal:  J Zhejiang Univ Sci B       Date:  2022-03-15       Impact factor: 3.066

Review 6.  N-Glycosylation and Inflammation; the Not-So-Sweet Relation.

Authors:  Barbara Radovani; Ivan Gudelj
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

Review 7.  The regulatory power of glycans and their binding partners in immunity.

Authors:  Jenny L Johnson; Mark B Jones; Sean O Ryan; Brian A Cobb
Journal:  Trends Immunol       Date:  2013-02-26       Impact factor: 16.687

8.  Hypomorphic MGAT5 polymorphisms promote multiple sclerosis cooperatively with MGAT1 and interleukin-2 and 7 receptor variants.

Authors:  Carey F Li; Raymond W Zhou; Haik Mkhikian; Barbara L Newton; Zhaoxia Yu; Michael Demetriou
Journal:  J Neuroimmunol       Date:  2013-01-22       Impact factor: 3.478

Review 9.  What Have We Learned from Glycosyltransferase Knockouts in Mice?

Authors:  Pamela Stanley
Journal:  J Mol Biol       Date:  2016-03-31       Impact factor: 5.469

10.  Interleukin-7 expression in tears and orbital tissues of patients with Graves' ophthalmopathy.

Authors:  KeBo Cai; RuiLi Wei
Journal:  Endocrine       Date:  2012-11-28       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.